Zhixuan Wu

机构：Guangxi Medical University, Sir Run Run Shaw Hospital, Integrated Chinese Medicine (China), Zhejiang Lab, Zhejiang University · ORCID：0000-0003-0141-4785

发表论文 36 篇 · 总被引 280 次 · h-index 11

代表论文

• A pan-cancer multi-omics analysis of lactylation genes associated with tumor microenvironment and cancer development (2024 · Heliyon · 被引 28)
• Cyclovirobuxine D inhibits triple-negative breast cancer via YAP/TAZ suppression and activation of the FOXO3a/PINK1-Parkin pathway-induced mitophagy (2024 · Phytomedicine · 被引 19)
• Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancer (2024 · Molecular Medicine · 被引 19)
• α-Hederin causes ferroptosis in triple-negative breast cancer through modulating IRF1 to suppress GPX4 (2025 · Phytomedicine · 被引 17)
• An Interpretable Machine Learning Model for Predicting 5‐Year Survival in Breast Cancer Based on Integration of Proteomics and Clinical Data (2025 · iMetaMed · 被引 13)
• Author Correction: Development and validation of a prognostic signature of breast cancer based on drug absorption, distribution, metabolism and excretion (ADME)-related genes (2024 · Scientific Reports · 被引 13)